Skip to main content
CIN- L67120MH1995PLC084899


Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Dr. Lalchandani Labs Ltd.

NSE : BSE : 541299 ISIN CODE : INE871Z01013Industry : Hospitals & Medical Services

News

  • Dr. Lalchandani Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 17 Jul 2026 | 14:00 | Dion Global

    Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations for quarter ended June 2026more...

  • Dr. Lalchandani Labs - Board Meeting Outcome for Approval Of Audited Financial Statement For Half Year And Year Ended March 3 03 Jun 2026 | 21:38 | Dion Global

    Audited Financial Results for the quarter and year ended March 31 2026more...

  • Dr. Lalchandani Labs - Approval Of Audited Financial Results For The Half Year And Year Ended March 31, 2026 03 Jun 2026 | 21:27 | Dion Global

    Audited Financial Results for the half year and year ended March 31 2206more...

  • Dr. Lalchandani Labs - Announcement under Regulation 30 (LODR)-Meeting Updates 30 May 2026 | 19:30 | Dion Global

    Intimation of Postponement and Rescheduling of Board Meeting scheduled to be held on Today May 30 2026.more...

  • Dr. Lalchandani Labs - Opening Of New Centre At Dwarka Delhi 28 May 2026 | 18:14 | Dion Global

    We are pleased to inform that the Company has successfully opened a new strategic Centre at Dwarka New Delhi.more...

  • Dr. Lalchandani Labs - Board Meeting Intimation for Consideration And Approval Of Financial Results Of The Company For Half Y 27 May 2026 | 18:02 | Dion Global

    Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to c...more...

  • Dr. Lalchandani Labs - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 04 May 2026 | 12:49 | Dion Global

    Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Dr Lalchandani...more...

  • Dr. Lalchandani Labs - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr 2026 | 13:51 | Dion Global

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Dr Lalch...more...

  • Dr. Lalchandani Labs - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer 22 Apr 2026 | 16:36 | Dion Global

    Resignation of Mrs. Saniya Hussain from the position of Company Secretary and Compliance Officermore...

  • Dr. Lalchandani Labs - Reply To The Clarification Sought By BSE 13 Apr 2026 | 19:45 | Dion Global

    Reply to the clarification sought by exchange dated April 13 2026more...

  • Dr. Lalchandani Labs - Clarification sought from Dr Lalchandani Labs Ltd 13 Apr 2026 | 19:30 | Dion Global

    The Exchange has sought clarification from Dr Lalchandani Labs Ltd on April 13 2026 with reference to significant movement in price in order to ensur...more...

  • Dr. Lalchandani Labs has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026 10 Apr 2026 | 11:21 | Dion Global

    As of March 2026 32.90% is owned by Indian Promoters and 67.10% by Public. Top three Promoters holding highest number of shares of Dr. Lalch...more...

  • Dr. Lalchandani Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 09 Apr 2026 | 18:56 | Dion Global

    Certificate under Regulation 74(5) of SEBI DP Regulations for Quarter ended March 2026more...

  • Dr. Lalchandani Labs has submitted to BSE the Shareholding Pattern for the Period Ended March 02, 2026 10 Mar 2026 | 20:30 | Dion Global

    As of March 2026 32.90% is owned by Indian Promoters and 67.10% by Public. Top three Promoters holding highest number of shares of Dr. Lalch...more...

  • Dr. Lalchandani Labs - Approval Of Basis Of Allotment Under Right Issue 02 Mar 2026 | 22:01 | Dion Global

    Approval of basis of allotment under Right issuemore...

  • Dr. Lalchandani Labs - Board Meeting Outcome for Outcome Of Board Meeting Held On Monday March 02, 2026 02 Mar 2026 | 21:59 | Dion Global

    Board meeting for approval of basis of allotment for right issuemore...

  • Dr. Lalchandani Labs - Board Meeting Revised Outcome For Extension Of Issue Period 16 Feb 2026 | 15:14 | Dion Global

    We wish to inform you that the Board of Directors of the Company considered and approved the extension of closing date of the ongoing right issue. Th...more...

  • Dr. Lalchandani Labs - Board Meeting Outcome for Board Meeting Outcome For Extension Of Issue Period 16 Feb 2026 | 14:12 | Dion Global

    This is in reference to the Outcome of the Meeting of Board of Directors dated January 20 2026 we wish to inform you that the Board of Direc...more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex78154.25-0.49%
NSE Index24471.7-0.45%
B500DIVL503587.34-0.13%
BSE 1000 11087.15-0.27%
BSE 100LCTMC9235.33-0.44%
BSE Auto 64845.36-0.31%

Commodity

Gold1517391.02%
Silver2344340.92%
Copper1378.5238.03%
Crude Oil782321.99%
Lead209.756.03%
Mentha Oil1341.625.69%
Nickel1655115.80%

Currency

USD/INR 95.21(0.00 %)
GBP/INR 128.12(-0.03 %)
EUR/INR 109.72(-0.20 %)
JPY/INR 0.60(-0.57 %)
CAD/INR 67.90(0.00 %)
HKD/INR 12.13(0.01 %)